甲状腺疾病治疗的全球市场-成长,未来展望,竞争分析(2022年~2030年)
市场调查报告书
商品编码
1192911

甲状腺疾病治疗的全球市场-成长,未来展望,竞争分析(2022年~2030年)

Thyroid Gland Disorders Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2个工作天内

价格

罹患甲状腺疾病的患者增加,老年人口增加,甲状腺疾病的开发药剂中研究开发的高涨,预计在预测期间内牵引市场。

本报告提供全球甲状腺疾病治疗市场相关调查分析,市场动态,市场分析,企业简介等系统性资讯。

目录

第1章 序文

  • 报告的说明
    • 报告的目的
    • 目标受众
    • 主要的产品
  • 市场区隔
  • 调查手法
    • 阶段Ⅰ-2次调查
    • 阶段Ⅱ-1次调查
    • 阶段Ⅲ-专家的审查
    • 假设
    • 所采用的方法

第2章 摘要整理

  • 市场概述:全球甲状腺疾病治疗市场
  • 全球甲状腺疾病治疗市场(100万美元)(2021年):各治疗
  • 全球甲状腺疾病治疗市场(100万美元):各地区
  • 富有魅力的投资提案(2021年):各地区

第3章 甲状腺疾病治疗市场:竞争分析

  • 主要的甲状腺疾病治疗市场供应商的市场定位
  • 甲状腺疾病治疗市场供应商采用的策略
  • 主要的产业策略
  • 阶层分析:2021年和2030年的比较

第4章 甲状腺疾病治疗市场:常量分析和市场动态

  • 简介
  • 全球甲状腺疾病治疗市场金额(100万美元)(2020年~2030年)
  • 市场动态
    • 推动市场要素
    • 阻碍市场要素
    • 主要课题
    • 主要的机会
  • 促进因素与阻碍因素的影响分析
  • See-Saw分析

第5章 甲状腺疾病治疗市场,美金(100万)(2020年~2030年):各治疗

  • 市场概要
  • 成长和收益分析:2021年和2030年的比较
  • 市场区隔
    • 甲状腺机能低下症
    • 甲状腺功能亢进症

第6章 北美的甲状腺疾病治疗市场,美金(100万)(2020年~2030年)

第7章 英国及欧洲联盟的甲状腺疾病治疗市场,美金(100万)(2020年~2030年)

第8章 亚太地区的甲状腺疾病治疗市场,美金(100万)(2020年~2030年)

第9章 南美的甲状腺疾病治疗市场,美金(100万)(2020年~2030年)

第10章 中东及非洲的甲状腺疾病治疗市场,美金(100万)(2020年~2030年)

第11章 企业简介

  • Abbott Laboratories
  • Abbvie, Inc.
  • Allergan plc.
  • GlaxoSmithKline plc
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Lannett Company Inc.
  • Sonofi
  • Takeda Pharmaceutical Company Ltd
  • 其他的主要企业
Product Code: 137044-08-22

The thyroid gland disorders treatment market is propelling due to the factors such as rise in the patient base suffering from thyroid disorders, rising geriatric population and consistent introduction of innovative and novel therapeutics by market players leading to the growth of the market. Asia Pacific is expected to be the fastest growing market in the thyroid gland disorder treatment market due large patient base leading to large consumption of generic drugs for the treatment of thyroid diseases, especially in the countries such as China, India and Japan. Moreover, the growing research and development in the drug discovery of thyroid gland disorders would further drive the market during the forecast period.

The report offers strategic insights into the overall thyroid gland disorders treatment market along with the market size and estimates for the duration 2022 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of treatment and different geographical region. The treatment type segment studied for analyzing the overall thyroid gland disorders treatment market are hypothyroidism and hyperthyroidism treatment. The hypothyroidism treatment includes drugs such as levothroxine and liothyronine, while hyperthyroidism treatments include drugs such as imidazole and propacil. In order to help strategic decision makers, the report also includes competitive profiling of the leading players in thyroid gland disorders treatment market, attractive investment proposition market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Thyroid Gland Disorders Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Thyroid Gland Disorders Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatments

Hypothyroidism

Levothyroxine

Liothyronine

Hyperthyroidism

Imidazole

Propacil

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Thyroid Gland Disorders Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Thyroid Gland Disorders Treatment market?

Which is the largest regional market for Thyroid Gland Disorders Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Thyroid Gland Disorders Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Thyroid Gland Disorders Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Thyroid Gland Disorders Treatment Market
  • 2.2. Global Thyroid Gland Disorders Treatment Market, By Treatments, 2021 (US$ Million)
  • 2.3. Global Thyroid Gland Disorders Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Thyroid Gland Disorders Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Thyroid Gland Disorders Treatment Market Vendors
  • 3.2. Strategies Adopted by Thyroid Gland Disorders Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Thyroid Gland Disorders Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Thyroid Gland Disorders Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Hypothyroidism
      • 5.3.1.1. Levothyroxine
      • 5.3.1.2. Liothyronine
    • 5.3.2. Hyperthyroidism
      • 5.3.2.1. Imidazole
      • 5.3.2.2. Propacil

6. North America Thyroid Gland Disorders Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
  • 6.3.Thyroid Gland Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

7. UK and European Union Thyroid Gland Disorders Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
  • 7.3.Thyroid Gland Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

8. Asia Pacific Thyroid Gland Disorders Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
  • 8.3.Thyroid Gland Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

9. Latin America Thyroid Gland Disorders Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
  • 9.3.Thyroid Gland Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

10. Middle East and Africa Thyroid Gland Disorders Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
  • 10.3.Thyroid Gland Disorders Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Thyroid Gland Disorders Treatment Market: By Treatments, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Abbvie, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Allergan plc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. GlaxoSmithKline plc
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Merck KGaA
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Mylan N.V.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Novartis AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Lannett Company Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Sonofi
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Takeda Pharmaceutical Company Ltd
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Other Notable Players
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 2 Global Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 3 Global Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 4 North America Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 5 North America Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 6 North America Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 7 U.S. Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 8 U.S. Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 9 U.S. Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 10 Canada Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 11 Canada Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 12 Canada Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 19 UK Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 20 UK Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 21 UK Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 22 Germany Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 23 Germany Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 24 Germany Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 25 Spain Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 26 Spain Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 27 Spain Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 28 Italy Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 29 Italy Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 30 Italy Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 31 France Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 32 France Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 33 France Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 37 Asia Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 38 Asia Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 39 Asia Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 40 China Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 41 China Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 42 China Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 43 Japan Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 44 Japan Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 45 Japan Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 46 India Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 47 India Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 48 India Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 49 Australia Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 50 Australia Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 51 Australia Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 52 South Korea Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 53 South Korea Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 54 South Korea Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 55 Latin America Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 56 Latin America Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 57 Latin America Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 58 Brazil Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 59 Brazil Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 60 Brazil Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 61 Mexico Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 62 Mexico Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 63 Mexico Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 70 GCC Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 71 GCC Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 72 GCC Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 73 Africa Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 74 Africa Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 75 Africa Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market By Treatments, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market By Hypothyroidism, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market By Hyperthyroidism, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Thyroid Gland Disorders Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Thyroid Gland Disorders Treatment Market: Quality Assurance
  • FIG. 5 Global Thyroid Gland Disorders Treatment Market, By Treatments, 2021
  • FIG. 6 Global Thyroid Gland Disorders Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Thyroid Gland Disorders Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Thyroid Gland Disorders Treatment Market Players, 2021
  • FIG. 9 Global Thyroid Gland Disorders Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Thyroid Gland Disorders Treatment Market, By Treatments, 2021 Vs 2030, %
  • FIG. 11 U.S. Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Thyroid Gland Disorders Treatment Market (US$ Million), 2020 - 2030